InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Regnante Keith. Insider active across 1 company, notably Keros Therapeutics, Inc.. Cumulatively, 5 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €65k. History available since 8 June 2023. The latest transaction was disclosed on 18 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Regnante Keith is a declarant linked to Keros Therapeutics, Inc., where the listed role is CHIEF FINANCIAL OFFICER. He has 5 filings in total, and across the 5 most recent sampled filings, sales total 65376 EUR, with the first filing dated 2023-06-12 and the last filing dated 2026-02-20.